Trial intelligence / Profile preview

Tranexamic Acid for Gastrointestinal Bleeding

NCT03540368Completed

Sponsor
Universitas Indonesia
Start
Jul 2018
Primary completion
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in gastrointestinal bleeding comparing Tranexamic acid injection with Placebo (2 arms). Primary endpoint: Re-bleeding at 28 days. Started Jul 2018; status: completed.

02

Drugs

tranexamic acid
03

Conditions

gastrointestinal bleeding

Beyond the preview

Go deeper on NCT03540368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03540368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call